secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2024-03-01T23:59:59+00:00
Accession:  0001193125-24-055936
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Dr. Nolan Sigal resigns from Aileron board; Nasdaq confirms compliance with annual meeting rule
--------------------------------------------------------------------------------

- Dr. Nolan Sigal resigned from Board and Nominating Committee effective February 29, 2024; no disagreement cited.
- Company received Nasdaq letter confirming regained compliance with Listing Rule 5620 (annual meeting requirement) on February 29, 2024.
- No replacement director announced; Board size reduced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312524055936/0001193125-24-055936-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312524055936/d797289d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-055936

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer